Federal Register Notice: FDA is making available a draft document entitled Guidance for Industry: Recommendations for Implementing a Collection Program for Source Plasma Containing Disease-Associated and Other Immunoglobulin (IgG) Antibodies. The draft will assist source plasma manufacturers in submitting to FDA the appropriate information when implementing an IgG antibody collection program or when adding a new IgG antibody collection to an existing program. When finalized, the document would supersede the draft reviewers' guide entitled Disease Associated Antibody Collection Program, dated
